8. STOCK PLANS

On January 26, 2017, the Board of Directors of the Company declared a 4% stock dividend payable as of March 31, 2017. All stock options and restricted stock outstanding have been adjusted to give retroactive effect to stock dividends.

The following table presents the activity related to stock options for the three months ended June 30, 2017.

	Number of Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value			Weighted Average Remaining Contractual Term (in years)
Options outstanding at Beginning of Period		250,594	$	7.72
Granted		—		—
Expired		—		—
Cancelled / Forfeited		—		—
Exercised		—		—
Options outstanding at End of Period		250,594	$	7.72		$	1,063,197		7.24
Exercisable (vested) at End of Period		118,731	$	6.03		$	705,811		5.46

The following table presents the activity related to stock options for the six months ended June 30, 2017.

	Number of Shares			Weighted Average Exercise Price		Aggregate Intrinsic Value			Weighted Average Remaining Contractual Term (in years)
Options outstanding at Beginning of Period		227,549		$	8.12
Granted		60,520		$	11.54
Expired		(37,475	)	$	16.31
Cancelled / Forfeited		—			—
Exercised		—			—
Options outstanding at End of Period		250,594		$	7.72		$	1,063,197		7.24
Exercisable (vested) at End of Period		118,731		$	6.03		$	705,811		5.46

The weighted average grant date fair value per share of options granted during the six months ended June 30, 2017 was $2.78 per share.

As of June 30, 2017, there was $285,000 of total unrecognized compensation cost related to non-vested stock options. This cost is expected to be recognized over a weighted average period of approximately 2.94 years.

There was $53,000 of recognized compensation cost related to stock options granted for the six months ended June 30, 2017.

A summary of the weighted average assumptions used in valuing stock options during the three and six months ended June 30, 2017 is presented below:

	Three Months Ended June 30, 2017*		Six Months Ended June 30, 2017
Risk Free Interest Rate		—		1.89%

Expected Dividend Yield		—		0.00%

Expected Life in Years		—		5

Expected Price Volatility		—		22.88%

* There were no stock options granted during the three months ended June 30, 2017.

The following table presents the activity related to non-vested restricted stock for the three months ended June 30, 2017.

	Number of Shares			Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value	Weighted Average Remaining Contractual Term (in years)
Non-vested Restricted stock outstanding at Beginning of Period		108,461		$	8.01
Granted		—			—
Cancelled / Forfeited		(1,463	)	$	6.92
Exercised/Released/Vested		—			—
Non-vested restricted stock outstanding at End of Period		106,998		$	8.03	$1,278,626	2.87

The following table presents the activity related to non-vested restricted stock for the six months ended June 30, 2017.

	Number of Shares			Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value	Weighted Average Remaining Contractual Term (in years)
Non-vested Restricted stock outstanding at Beginning of Period		99,184		$	6.70
Granted		24,617		$	11.46
Cancelled / Forfeited		(1,463	)	$	6.92
Exercised/Released/Vested		(15,340	)	$	5.08
Non-vested restricted stock outstanding at End of Period		106,998		$	8.03	$1,278,626	2.87

The weighted average fair value of restricted stock granted during the six months ended June 30, 2017 was $11.46 per share.

As of June 30, 2017, there was $501,000 of total unrecognized compensation cost related to non-vested restricted stock. This cost is expected to be recognized over a weighted average period of approximately 2.87 years. There was $103,000 of recognized compensation cost related to restricted stock awards for the six months ended June 30, 2017.

The Company has an Employee Stock Purchase Plan ("ESPP"). There are 270,400 shares authorized under the ESPP. The total number of shares authorized has been adjusted to give retroactive effect to stock dividends and stock splits, including the 4% stock dividend declared on January 26, 2017, payable March 31, 2017 to shareholders of record as of February 28, 2017. The ESPP will expire on March 16, 2026.

The ESPP is implemented by participation periods of not more than 27 months each. The Board of Directors determines the commencement date and duration of each participation period. The Board of Directors approved the current participation period of December 10, 2016 to November 23, 2017. An eligible employee is one who has been continually employed for at least 90 days prior to commencement of a participation period. Under the terms of the ESPP, employees can choose to have up to 10 percent of their compensation withheld to purchase the Company's common stock each participation period. The purchase price of the stock is 85 percent of the lower of the fair value on the last trading day before the date of participation or the fair value on the last trading day during the participation period.

As of June 30, 2017, there was $9,000 of unrecognized compensation cost related to ESPP issuances. This cost is expected to be recognized over a weighted average period of approximately 0.50 years.

There was $9,000 of recognized compensation cost related to ESPP issuances for the six months ended June 30, 2017.

The weighted average fair value at issuance date during the six months ended June 30, 2017 was $1.74 per share.

A summary of the weighted average assumptions used in valuing ESPP issuances during the three and six months ended June 30, 2017 is presented below.

	Three Months Ended June 30, 2017		Six Months Ended June 30, 2017
Risk Free Interest Rate		0.85%		0.85%

Expected Dividend Yield		0.00%		0.00%

Expected Life in Years		1.00		1.00

Expected Price Volatility		8.18%		8.18%